Skip to main content
Erschienen in: Breast Cancer Research and Treatment 2/2010

01.06.2010 | Epidemiology

Coffee and tea intake and risk of breast cancer

verfasst von: Nirmala Bhoo Pathy, Petra Peeters, Carla van Gils, Joline W. J. Beulens, Yolanda van der Graaf, Bas Bueno-de-Mesquita, Awang Bulgiba, Cuno S. P. M. Uiterwaal

Erschienen in: Breast Cancer Research and Treatment | Ausgabe 2/2010

Einloggen, um Zugang zu erhalten

Abstract

Known risk factors account for about 10–15% of breast cancer incidence suggesting that lifestyle exposures are crucial in its etiology. Previous epidemiological studies on the association between coffee and tea consumption and breast cancer risk have been inconsistent. We investigated the association of coffee and tea consumption with the risk of breast cancer among women in EPIC-NL cohort, a population-based prospective cohort in Netherlands with 27,323 participants. Exposure was measured by a validated food frequency questionnaire, and the outcome was verified by direct linkage with the Netherlands Cancer Registry. A total of 681 invasive primary breast cancers were diagnosed in 9.6 years of follow-up. Coffee intake increased the risk of breast cancer by more than twofold as compared to non-consumers (HR; 2.25, 95% CI; 1.30–3.90). This association did not hold after multivariate adjustment which resulted in a HR of 1.17, 95% CI; 0.65–2.12. After adjustment to breast cancer risk factors and lifestyle, no association was observed between intake of coffee or tea and risk of breast cancer across all categories of intake. These results were also not altered by body mass index (BMI). Coffee and tea consumption does not seem to be related to the risk of breast cancer in women.
Literatur
1.
Zurück zum Zitat Parkin MD, Bray F, Ferlay J, Pisani P (2005) Global Cancer Statistics, 2002. CA Cancer J Clin 55:74–108CrossRefPubMed Parkin MD, Bray F, Ferlay J, Pisani P (2005) Global Cancer Statistics, 2002. CA Cancer J Clin 55:74–108CrossRefPubMed
2.
Zurück zum Zitat World Cancer Research Fund/American Institute for Cancer Research (2007) Food, nutrition, physical activity, and the prevention of cancer: a global perspective. Washington DC: AICR World Cancer Research Fund/American Institute for Cancer Research (2007) Food, nutrition, physical activity, and the prevention of cancer: a global perspective. Washington DC: AICR
3.
Zurück zum Zitat McLaughlin CC, Mahoney MC, Nasca PC et al (1992) Breast cancer and methylxanthine consumption. Cancer Causes Control 3(2):175–178CrossRefPubMed McLaughlin CC, Mahoney MC, Nasca PC et al (1992) Breast cancer and methylxanthine consumption. Cancer Causes Control 3(2):175–178CrossRefPubMed
4.
Zurück zum Zitat Ewertz M, Gill C (1990) Dietary factors and breast cancer risk in Denmark. Int J Cancer 46(5):779–784CrossRefPubMed Ewertz M, Gill C (1990) Dietary factors and breast cancer risk in Denmark. Int J Cancer 46(5):779–784CrossRefPubMed
5.
Zurück zum Zitat Tavani A, Pregnolato A, La Vecchia C et al (1998) Coffee consumption and the risk of breast cancer. Eur J Cancer Prev 7(1):77–82PubMed Tavani A, Pregnolato A, La Vecchia C et al (1998) Coffee consumption and the risk of breast cancer. Eur J Cancer Prev 7(1):77–82PubMed
6.
Zurück zum Zitat Wu AH, Yu MC, Tseng CC et al (2003) Green tea and risk of breast cancer in Asian Americans. Int J Cancer 106:574–579CrossRefPubMed Wu AH, Yu MC, Tseng CC et al (2003) Green tea and risk of breast cancer in Asian Americans. Int J Cancer 106:574–579CrossRefPubMed
7.
Zurück zum Zitat Mannisto S, Pietinen P, Virtanen V et al (1999) Diet and the risk of breast cancer in a case-control study: does the threat of disease have an influence on recall bias? J Clin Epidemiol 52:429–439CrossRefPubMed Mannisto S, Pietinen P, Virtanen V et al (1999) Diet and the risk of breast cancer in a case-control study: does the threat of disease have an influence on recall bias? J Clin Epidemiol 52:429–439CrossRefPubMed
8.
Zurück zum Zitat Kumar N, Titus-Ernstoff L, Newcomb PA et al. (2009) Tea consumption and risk of breast cancer. Cancer Epidemiol Biomarkers Prev 18(1):341–345 Kumar N, Titus-Ernstoff L, Newcomb PA et al. (2009) Tea consumption and risk of breast cancer. Cancer Epidemiol Biomarkers Prev 18(1):341–345
9.
Zurück zum Zitat Baker JA, Beehler GP, Sawant AC et al (2006) Consumption of coffee, but not black tea, is associated with decreased risk of premenopausal breast cancer. J Nutr 136:166–171PubMed Baker JA, Beehler GP, Sawant AC et al (2006) Consumption of coffee, but not black tea, is associated with decreased risk of premenopausal breast cancer. J Nutr 136:166–171PubMed
10.
Zurück zum Zitat Zhang M, Holman CDJ, Huang JP, Xie X (2007) Green tea and the prevention of breast cancer: a case control study in Southeast China. Carcinogenesis 28(5):1074–1078CrossRefPubMed Zhang M, Holman CDJ, Huang JP, Xie X (2007) Green tea and the prevention of breast cancer: a case control study in Southeast China. Carcinogenesis 28(5):1074–1078CrossRefPubMed
11.
Zurück zum Zitat Rosenberg L, Miller DR, Helmrich SP et al (1985) Breast cancer and the consumption of coffee. Am J Epidemiol 122(3):391–399PubMed Rosenberg L, Miller DR, Helmrich SP et al (1985) Breast cancer and the consumption of coffee. Am J Epidemiol 122(3):391–399PubMed
12.
Zurück zum Zitat Zheng W, Doyle TJ, Kushi LH et al (1996) Tea consumption and cancer incidence in a prospective cohort study of postmenopausal women. Am J Epidemiol 144:175–182PubMed Zheng W, Doyle TJ, Kushi LH et al (1996) Tea consumption and cancer incidence in a prospective cohort study of postmenopausal women. Am J Epidemiol 144:175–182PubMed
13.
Zurück zum Zitat Folsom AR, McKenzie DR, Bisgard KM et al (1993) No association between caffeine intake and postmenopausal breast cancer incidence in the Iowa Women’s Health Study. Am J Epidemiol 138:380–383PubMed Folsom AR, McKenzie DR, Bisgard KM et al (1993) No association between caffeine intake and postmenopausal breast cancer incidence in the Iowa Women’s Health Study. Am J Epidemiol 138:380–383PubMed
14.
Zurück zum Zitat Suzuki Y, Tsubono Y, Nakaya N et al (2004) Green tea and the risk of breast cancer: pooled analysis of two prospective studies in Japan. Br J Cancer 90:1361–1363CrossRefPubMed Suzuki Y, Tsubono Y, Nakaya N et al (2004) Green tea and the risk of breast cancer: pooled analysis of two prospective studies in Japan. Br J Cancer 90:1361–1363CrossRefPubMed
15.
Zurück zum Zitat Ganmaa D, Willet WC, Li TY et al (2008) Coffee, tea, caffeine and risk of breast cancer: a 22-year follow-up. Int J Cancer 122:2071–2076CrossRefPubMed Ganmaa D, Willet WC, Li TY et al (2008) Coffee, tea, caffeine and risk of breast cancer: a 22-year follow-up. Int J Cancer 122:2071–2076CrossRefPubMed
16.
Zurück zum Zitat Ishitani K, Lin J, Manson JE (2008) Caffeine consumption and the risk of breast cancer in a large prospective cohort of women. Arch Intern Med 168(18):2022–2031CrossRefPubMed Ishitani K, Lin J, Manson JE (2008) Caffeine consumption and the risk of breast cancer in a large prospective cohort of women. Arch Intern Med 168(18):2022–2031CrossRefPubMed
17.
Zurück zum Zitat Michels KB, Holmberg L, Bergkvist L et al (2002) Coffee, tea, and caffeine consumption and breast cancer incidence in a cohort of Swedish Women. Ann Epidemiol 12(1):21–26CrossRefPubMed Michels KB, Holmberg L, Bergkvist L et al (2002) Coffee, tea, and caffeine consumption and breast cancer incidence in a cohort of Swedish Women. Ann Epidemiol 12(1):21–26CrossRefPubMed
18.
Zurück zum Zitat Hirvonen T, Mennen LI, de Bree A et al (2006) Consumption of antioxidant-rich beverages and risk for breast cancer in French women. Ann Epidemiol 16:503–508CrossRefPubMed Hirvonen T, Mennen LI, de Bree A et al (2006) Consumption of antioxidant-rich beverages and risk for breast cancer in French women. Ann Epidemiol 16:503–508CrossRefPubMed
19.
Zurück zum Zitat Vatten LJ, Solvoll K, Loken EB (1990) Coffee consumption and the risk of breast cancer. A prospective study of 14, 593 Norwegian women. Br J Cancer 62(2):267–270PubMed Vatten LJ, Solvoll K, Loken EB (1990) Coffee consumption and the risk of breast cancer. A prospective study of 14, 593 Norwegian women. Br J Cancer 62(2):267–270PubMed
20.
Zurück zum Zitat Scalbert A, Williamson G (2000) Dietary intake and bioavailability of polyphenols. J Nutr 130:2073–2085 Scalbert A, Williamson G (2000) Dietary intake and bioavailability of polyphenols. J Nutr 130:2073–2085
21.
Zurück zum Zitat Welsch CW, Scieszka KM, Senn ER et al (1983) Caffeine (1, 3, 7-trimethylxanthine), a temperate promoter of DMBA-induced rat mammary gland carcinogenesis. Int J Cancer 32(4):479–484CrossRefPubMed Welsch CW, Scieszka KM, Senn ER et al (1983) Caffeine (1, 3, 7-trimethylxanthine), a temperate promoter of DMBA-induced rat mammary gland carcinogenesis. Int J Cancer 32(4):479–484CrossRefPubMed
22.
Zurück zum Zitat Trosko JE, Chu HY (1973) Inhibition of repair of UV-damaged DNA by caffeine and mutation induction in Chinese hamster cells. Chem Biol Interact 6(5):317–322CrossRefPubMed Trosko JE, Chu HY (1973) Inhibition of repair of UV-damaged DNA by caffeine and mutation induction in Chinese hamster cells. Chem Biol Interact 6(5):317–322CrossRefPubMed
23.
Zurück zum Zitat Wang LQ (2002) Mammalian phytoestrogens: enterodiol and enterolactone. J Chromatogr B Analyt Technol Biomed Life Sci 777(1–2):289–309PubMed Wang LQ (2002) Mammalian phytoestrogens: enterodiol and enterolactone. J Chromatogr B Analyt Technol Biomed Life Sci 777(1–2):289–309PubMed
25.
Zurück zum Zitat Brooks JD, Thompson LU (2005) Mammalian lignans and genistein decrease the activities of aromatase and 17beta-hydroxysteroid dehydrogenase in MCF-7 cells. J Steroid Biochem Mol Biol 94(5):461–467CrossRefPubMed Brooks JD, Thompson LU (2005) Mammalian lignans and genistein decrease the activities of aromatase and 17beta-hydroxysteroid dehydrogenase in MCF-7 cells. J Steroid Biochem Mol Biol 94(5):461–467CrossRefPubMed
26.
Zurück zum Zitat Riboli E, Kaaks R (1997) The EPIC project: rationale and study design. Int J Epidemiol 26:S6–S14CrossRefPubMed Riboli E, Kaaks R (1997) The EPIC project: rationale and study design. Int J Epidemiol 26:S6–S14CrossRefPubMed
27.
Zurück zum Zitat Boker LK, Van Noord PAH, Van Der Schouw YT et al (2001) Prospect-EPIC Utrecht: study design and characteristics of the cohort population. Eur J Epidemiol 17:1047–1053CrossRefPubMed Boker LK, Van Noord PAH, Van Der Schouw YT et al (2001) Prospect-EPIC Utrecht: study design and characteristics of the cohort population. Eur J Epidemiol 17:1047–1053CrossRefPubMed
28.
Zurück zum Zitat Blokstra A, Seidell JC, Smit HA et al. (1998) The monitoring project on risk factors for chronic diseases (MORGEN project) annual report 1997 (in Dutch). RIVM (National Institute for Public Health and the Environment), Bilthoven, Netherlands Blokstra A, Seidell JC, Smit HA et al. (1998) The monitoring project on risk factors for chronic diseases (MORGEN project) annual report 1997 (in Dutch). RIVM (National Institute for Public Health and the Environment), Bilthoven, Netherlands
29.
Zurück zum Zitat Ocké MC, Bueno-de-Mesquita HB, Goddijn HE et al (1997) The Dutch EPIC Food Frequency Questionnaire I. Description of the questionnaire, and relative validity and reproducibility for food groups. Int J Epidemiol 26:S37–S48CrossRefPubMed Ocké MC, Bueno-de-Mesquita HB, Goddijn HE et al (1997) The Dutch EPIC Food Frequency Questionnaire I. Description of the questionnaire, and relative validity and reproducibility for food groups. Int J Epidemiol 26:S37–S48CrossRefPubMed
30.
Zurück zum Zitat Ocké MC, Bueno-de-Mesquita HB, Pols MA, Smit HA, Van Staveren WA, Kromhout D (1997) The Dutch EPIC Food Frequency Questionnaire II. Relative validity and reproducibility for nutrients. Int J Epidemiol 26:S49–S58CrossRefPubMed Ocké MC, Bueno-de-Mesquita HB, Pols MA, Smit HA, Van Staveren WA, Kromhout D (1997) The Dutch EPIC Food Frequency Questionnaire II. Relative validity and reproducibility for nutrients. Int J Epidemiol 26:S49–S58CrossRefPubMed
31.
32.
Zurück zum Zitat D’Agostino RB (1998) Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group. Stat Med 17:2265–2281CrossRefPubMed D’Agostino RB (1998) Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group. Stat Med 17:2265–2281CrossRefPubMed
33.
Zurück zum Zitat Kurth T, Walker AM, Glynn RJ et al (2006) Results of multivariable logistic regression, propensity matching, and propensity-based weighting under conditions of nonuniform effect. Am J Epidemiol 163:262–270CrossRefPubMed Kurth T, Walker AM, Glynn RJ et al (2006) Results of multivariable logistic regression, propensity matching, and propensity-based weighting under conditions of nonuniform effect. Am J Epidemiol 163:262–270CrossRefPubMed
34.
Zurück zum Zitat Willett WC, Howe GR, Kushi LH (1997) Adjustment for total energy intake in epidemiologic studies. Am J Clin Nutr 65:1220S–1228SPubMed Willett WC, Howe GR, Kushi LH (1997) Adjustment for total energy intake in epidemiologic studies. Am J Clin Nutr 65:1220S–1228SPubMed
35.
Zurück zum Zitat Tang N, Zhou B, Wang B, et al. (2009) Coffee consumption and risk of breast cancer: a metaanalysis. Am J Obstet Gynecol 200(3):290.e1–290.e9 Tang N, Zhou B, Wang B, et al. (2009) Coffee consumption and risk of breast cancer: a metaanalysis. Am J Obstet Gynecol 200(3):290.e1–290.e9
36.
Zurück zum Zitat Luo J, Inoue M, Iwasaki M et al (2007) Green tea and coffee intake and risk of pancreatic cancer in a large scale, population based cohort study in Japan (JPHC study). Eur J Cancer Prev 16(6):542–548CrossRefPubMed Luo J, Inoue M, Iwasaki M et al (2007) Green tea and coffee intake and risk of pancreatic cancer in a large scale, population based cohort study in Japan (JPHC study). Eur J Cancer Prev 16(6):542–548CrossRefPubMed
Metadaten
Titel
Coffee and tea intake and risk of breast cancer
verfasst von
Nirmala Bhoo Pathy
Petra Peeters
Carla van Gils
Joline W. J. Beulens
Yolanda van der Graaf
Bas Bueno-de-Mesquita
Awang Bulgiba
Cuno S. P. M. Uiterwaal
Publikationsdatum
01.06.2010
Verlag
Springer US
Erschienen in
Breast Cancer Research and Treatment / Ausgabe 2/2010
Print ISSN: 0167-6806
Elektronische ISSN: 1573-7217
DOI
https://doi.org/10.1007/s10549-009-0583-y

Weitere Artikel der Ausgabe 2/2010

Breast Cancer Research and Treatment 2/2010 Zur Ausgabe

Umsetzung der POMGAT-Leitlinie läuft

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

CUP-Syndrom: Künstliche Intelligenz kann Primärtumor finden

30.04.2024 Künstliche Intelligenz Nachrichten

Krebserkrankungen unbekannten Ursprungs (CUP) sind eine diagnostische Herausforderung. KI-Systeme können Pathologen dabei unterstützen, zytologische Bilder zu interpretieren, um den Primärtumor zu lokalisieren.

Sind Frauen die fähigeren Ärzte?

30.04.2024 Gendermedizin Nachrichten

Patienten, die von Ärztinnen behandelt werden, dürfen offenbar auf bessere Therapieergebnisse hoffen als Patienten von Ärzten. Besonders gilt das offenbar für weibliche Kranke, wie eine Studie zeigt.

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.